Long-term monitoring of HIV-infected patients in France

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect and analyze clinical, laboratory, and therapeutic data from over 30,000 HIV-infected patients across 15 HIV centers in France. The study focuses on understanding the clinical practice and changes in the management of HIV and related co-infections over time. It evaluates the effectiveness of antiretroviral therapy (ART) and monitors the treatment outcomes for hepatitis C virus (HCV) among the cohort. Data is collected as part of routine care during scheduled outpatient visits, regardless of patients' CD4 cell count or ART status.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* HIV-1 infected patients regardless of CD4 cell count and antiretroviral therapy status

Exclusion Criteria:

* Patients under 18 years of age
* Patients without written informed consent

Where it's running

• Hôpital Nord Franche Comté
  Belfort, France Recruiting
• CHU Besançon - Hôpital Jean Minjoz
  Besançon, France Recruiting
• CHRU Brest
  Brest, France Recruiting
• Centre Hospitalier de Brive
  Brive-la-Gaillarde, France Recruiting
• CHU Clermont-Ferrand - Hôpital Gabriel-Montpied
  Clermont-Ferrand, France Recruiting
• Chic
  Créteil, France Recruiting

Study contacts

• Principal investigator: Pascal PUGLIESE, MD — Centre Hospitalier Universitaire de Nice
• Study coordinator: Pascal Pugliese, MD
• Email: pugliese.p@chu-nice.fr
• Phone: 0033492035802

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Project SHIELD 2.0: Police Education to Support Public Health in Kentucky

  Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Lexington, Kentucky · NCT07804121

• New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV

  This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.

  Recruiting Indiana University · Lilongwe · NCT07793006

• Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV

  This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.

  Recruiting Fenway Community Health · Boston, Massachusetts · NCT07762066

• HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters

  This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.

  Recruiting at 2 sites Phase 1 National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California and 7 other locations · NCT07757802

• Stigma-reducing program to help women who use drugs stay in HIV care

  This test checks whether a stigma-reduction program helps women living with HIV who use drugs stay engaged in HIV care in Ukraine.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Kyiv, Kyiv Oblast · NCT07751978

• Platelets and HIV Reservoirs: A look at how platelets might harbor HIV in people living with HIV

  This observational study tests whether HIV can be found inside platelets in adults with suppressed HIV on therapy.

  Recruiting Tourcoing Hospital · Tourcoing · NCT07745530

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.